Who Paid My Doc
V.A.C. Veraflo Cleanse Choice
Device Negative Pressure Systems & Dressings
PDI 00849554006256
General payments
$2,614,865
Research payments
$500,644
Through program year 2025, $2,614,865 in general payments and $500,644 in research payments were reported against V.A.C. Veraflo Cleanse Choice (Negative Pressure Systems & Dressings).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $150,613 | 2,027 |
| 2025 | Research | $111,548 | 6 |
| 2024 | General | $702,598 | 1,868 |
| 2024 | Research | $25,000 | 1 |
| 2023 | General | $736,091 | 1,700 |
| 2023 | Research | $14,700 | 3 |
| 2022 | General | $679,596 | 1,264 |
| 2022 | Research | $225,208 | 22 |
| 2021 | General | $345,967 | 1,135 |
| 2021 | Research | $124,187 | 26 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 78 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 45 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
7,994 general · 58 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.